228 related articles for article (PubMed ID: 32704131)
1. Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity.
Piegari E; Cozzolino A; Ciuffreda LP; Cappetta D; De Angelis A; Urbanek K; Rossi F; Berrino L
Sci Rep; 2020 Jul; 10(1):12250. PubMed ID: 32704131
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.
Piegari E; Russo R; Cappetta D; Esposito G; Urbanek K; Dell'Aversana C; Altucci L; Berrino L; Rossi F; De Angelis A
Oncotarget; 2016 Sep; 7(38):62312-62326. PubMed ID: 27694688
[TBL] [Abstract][Full Text] [Related]
3. Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity.
Zhu JN; Fu YH; Hu ZQ; Li WY; Tang CM; Fei HW; Yang H; Lin QX; Gou DM; Wu SL; Shan ZX
Sci Rep; 2017 Sep; 7(1):11879. PubMed ID: 28928469
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.
Cappetta D; Esposito G; Piegari E; Russo R; Ciuffreda LP; Rivellino A; Berrino L; Rossi F; De Angelis A; Urbanek K
Int J Cardiol; 2016 Feb; 205():99-110. PubMed ID: 26730840
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.
Xia W; Hou M
Oncol Lett; 2018 Jun; 15(6):10037-10046. PubMed ID: 29928373
[TBL] [Abstract][Full Text] [Related]
6. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Russo M; Guida F; Paparo L; Trinchese G; Aitoro R; Avagliano C; Fiordelisi A; Napolitano F; Mercurio V; Sala V; Li M; Sorriento D; Ciccarelli M; Ghigo A; Hirsch E; Bianco R; Iaccarino G; Abete P; Bonaduce D; Calignano A; Berni Canani R; Tocchetti CG
Eur J Heart Fail; 2019 Apr; 21(4):519-528. PubMed ID: 30843309
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a regulation of endothelial senescence.
Ito T; Yagi S; Yamakuchi M
Biochem Biophys Res Commun; 2010 Aug; 398(4):735-40. PubMed ID: 20627091
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.
De Angelis A; Piegari E; Cappetta D; Russo R; Esposito G; Ciuffreda LP; Ferraiolo FA; Frati C; Fagnoni F; Berrino L; Quaini F; Rossi F; Urbanek K
Int J Cardiol; 2015; 189():30-44. PubMed ID: 25889431
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.
Xu C; Liu CH; Zhang DL
Biochem Biophys Res Commun; 2020 Jan; 521(2):485-491. PubMed ID: 31677784
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
Pecoraro M; Del Pizzo M; Marzocco S; Sorrentino R; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
Toxicol Appl Pharmacol; 2016 Feb; 293():44-52. PubMed ID: 26780402
[TBL] [Abstract][Full Text] [Related]
11. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
[TBL] [Abstract][Full Text] [Related]
12. Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes.
Sirangelo I; Sapio L; Ragone A; Naviglio S; Iannuzzi C; Barone D; Giordano A; Borriello M
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32752227
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
Jing X; Yang J; Jiang L; Chen J; Wang H
Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
[TBL] [Abstract][Full Text] [Related]
14. Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.
Zhang F; Cui J; Liu X; Lv B; Liu X; Xie Z; Yu B
Stem Cell Res Ther; 2015 Oct; 6():195. PubMed ID: 26446137
[TBL] [Abstract][Full Text] [Related]
15. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle.
Rodrigues PG; Miranda-Silva D; Costa SM; Barros C; Hamdani N; Moura C; Mendes MJ; Sousa-Mendes C; Trindade F; Fontoura D; Vitorino R; Linke WA; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H459-H475. PubMed ID: 30525890
[TBL] [Abstract][Full Text] [Related]
16. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
[TBL] [Abstract][Full Text] [Related]
17. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity.
Rocca C; Scavello F; Colombo B; Gasparri AM; Dallatomasina A; Granieri MC; Amelio D; Pasqua T; Cerra MC; Tota B; Corti A; Angelone T
FASEB J; 2019 Jun; 33(6):7734-7747. PubMed ID: 30973759
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.
Wang A J; Zhang J; Xiao M; Wang S; Wang B J; Guo Y; Tang Y; Gu J
Cell Mol Life Sci; 2021 Apr; 78(7):3105-3125. PubMed ID: 33438055
[TBL] [Abstract][Full Text] [Related]
19. Suppression of miR-34a Expression in the Myocardium Protects Against Ischemia-Reperfusion Injury Through SIRT1 Protective Pathway.
Fu BC; Lang JL; Zhang DY; Sun L; Chen W; Liu W; Liu KY; Ma CY; Jiang SL; Li RK; Tian H
Stem Cells Dev; 2017 Sep; 26(17):1270-1282. PubMed ID: 28599575
[TBL] [Abstract][Full Text] [Related]
20. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
